Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon‐γ or interleukin‐10 are expanded in asymptomatic, E antigen‐negative patients with persistent hepatitis B virus infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 335-345

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced interferon‐α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 179, Iss. 2, 2015-02 ,pp. : 245-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type I Interferon Plays Opposing Roles in Cytotoxicity and Interferon-γ Production by Natural Killer and CD8⁺ T Cells after Influenza A Virus Infection in Mice

By  

Journal of Innate Immunity, Vol. 6, Iss. 4, 2014-01 ,pp. : 456-466

Karger

Access to resources Recommend Favorite

P099: Flunarizine, a clinically licensed diphenylmethylpiperazine and T‐type calcium channel inhibitor prevents Hepatitis C virus membrane fusion in a genotype‐dependent manner

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 70-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

P102: Antiviral activity of human Kupffer cells, liver sinusoidal endothelial cells and hepatic stellate cells against Hepatitis C virus is restricted to toll‐like receptor 3 stimulation and involves type I interferons

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 71-72

John Wiley & Sons Inc

Access to resources Recommend Favorite